Mesoblast Limited (MESO)
NASDAQ·Healthcare·Biotechnology
$14.18
-1.87%
Mkt Cap $1.99B
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$11.50
Range $11.00 – $12.00
Implied Upside
-18.9%
Consensus $11.50 vs current $14.18
NASDAQ·Healthcare·Biotechnology
$14.18
-1.87%
Mkt Cap $1.99B
No recent rating data.
Price Target (2 analysts)
$11.50
Range $11.00 – $12.00
-18.9%
Consensus $11.50 vs current $14.18